Lexicon Pharmaceuticals, Inc. (LXRX)
Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 45
+0.03
+2.1127%
After Hours
$
+0.1 +6.8966% 1. 55
676.33M Market Cap
- P/E Ratio
- Div Yield
2.21M Volume
-0.71 Eps
$ 1.42
Previous Close Want to track LXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lexicon Pharmaceuticals, Inc. (LXRX) Statistics
Valuation metrics
Market Cap 676.33M
Enterprise value 650.19M
Trailing P/E (ttm) -9.44
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) 15.24
Price/Book (mrq) 3.56
Enterprise Value/Revenue 15.68
Enterprise Value/EBITDA -12.44
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.74M
Average volume (90 days) 2.76M
Price summary
52-Week low 1.1
52-Week high 2.68
Beta -
50-Day moving average 1.84
200-Day moving average 2.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:7
Last split Date 21 May 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.47%
Operating margin -1.31%
Operational effectiveness
Return on assets -0.24%
Return on equity -0.4%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.44
Total debt (mrq) -
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 13.37%
Book value per share (mrq) 0.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
